<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy - Hwang, EC - 2019 | Cochrane Library</title> <meta content="Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy - Hwang, EC - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013336/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy - Hwang, EC - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013336/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013336" name="dc.identifier" scheme="DOI"/> <meta content="Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy" name="citation_title"/> <meta content="Eu Chang Hwang" name="citation_author"/> <meta content="Chonnam National University Medical School, Chonnam National University Hwasun Hospital" name="citation_author_institution"/> <meta content="urohwang@gmail.com" name="citation_author_email"/> <meta content="Niranjan J Sathianathen" name="citation_author"/> <meta content="University of Minnesota" name="citation_author_institution"/> <meta content="Mari Imamura" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Gretchen M Kuntz" name="citation_author"/> <meta content="University of Florida‐Jacksonville" name="citation_author_institution"/> <meta content="Michael C Risk" name="citation_author"/> <meta content="Minneapolis VA Health Care System" name="citation_author_institution"/> <meta content="Philipp Dahm" name="citation_author"/> <meta content="Minneapolis VA Health Care System" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD013336" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/05/14" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013336/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013336/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013336/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Cystectomy [methods]; *Lymph Node Excision; Carcinoma, Transitional Cell [*surgery]; Postoperative Complications; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Bladder Neoplasms [*surgery]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013336&amp;doi=10.1002/14651858.CD013336&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="BqmVIxTs";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013336\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013336\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013336\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fr","de","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013336",title:"Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy",firstPublishedDate:"May 14, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Urology Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013336&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013336';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013336/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013336/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013336%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013336/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013336/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013336/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013336/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013336" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013336/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013336" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013336/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013336/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2220 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013336" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-sec-0108"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-sec-0043"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-sec-0044"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-sec-0073"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-sec-0102"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013336/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/appendices#CD013336-sec-0113"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/table_n/CD013336StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/table_n/CD013336StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013336/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013336/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013336/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013336/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013336/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013336/information#CD013336-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Eu Chang Hwang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013336/information#CD013336-cr-0003">Niranjan J Sathianathen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013336/information#CD013336-cr-0004">Mari Imamura</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013336/information#CD013336-cr-0005">Gretchen M Kuntz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013336/information#CD013336-cr-0006">Michael C Risk</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013336/information#CD013336-cr-0007">Philipp Dahm</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013336/information/en#CD013336-sec-0117">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 14 May 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013336/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013336">https://doi.org/10.1002/14651858.CD013336</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013336-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013336-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013336-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013336-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013336-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013336-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013336-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013336-abs-0001" lang="en"> <section id="CD013336-sec-0001"> <h3 class="title" id="CD013336-sec-0001">Background</h3> <p>In the treatment of urothelial carcinoma of the bladder, we are currently uncertain of the benefits and harms of standard pelvic lymph node dissection (PLND) compared to extended PLND. </p> </section> <section id="CD013336-sec-0002"> <h3 class="title" id="CD013336-sec-0002">Objectives</h3> <p>To assess the effects of extended versus standard PLND in patients undergoing cystectomy to treat muscle‐invasive (cT2 and cT3) and treatment‐refractory, non‐muscle‐invasive (cT1 with or without carcinoma in situ) urothelial carcinoma of the bladder. </p> </section> <section id="CD013336-sec-0003"> <h3 class="title" id="CD013336-sec-0003">Search methods</h3> <p>We performed a comprehensive literature search using multiple databases (PubMed, Embase, Cochrane Controlled Trials, Web of Science, and LILACS), trial registries, and conference proceedings published up to April 29, 2019, with no restrictions on the language or status of publication. </p> </section> <section id="CD013336-sec-0004"> <h3 class="title" id="CD013336-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials in which participants underwent radical cystectomy (RC) for muscle‐invasive or therapy‐refractory non‐muscle‐invasive urothelial carcinoma of the bladder with either an extended PLND with a superior extent reaching as far cranially as the inferior mesenteric vein, or a standard PLND with a superior extent of the bifurcation of the internal and external iliac artery, with otherwise the same anatomical boundaries. </p> </section> <section id="CD013336-sec-0005"> <h3 class="title" id="CD013336-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the included studies and extracted data from them for the primary outcomes: time to death from any cause, time to death from bladder cancer and Clavien‐Dindo classification of surgical complications grade III‐V, and the secondary outcomes: time to recurrence, Clavien‐Dindo I‐II complications and disease‐specific quality of life. </p> <p>We performed statistical analyses using a random‐effects model and rated the certainty of evidence according to the GRADE approach. </p> </section> <section id="CD013336-sec-0006"> <h3 class="title" id="CD013336-sec-0006">Main results</h3> <p>The search identified one multicenter trial based in Germany that enrolled 401 participants with histologically confirmed T1 grade 3 or muscle‐invasive urothelial carcinoma. The median age was 67 years (range: 59 to 74) and the majority of participants were male (78.3%). No participant received neoadjuvant chemotherapy; a small subset received adjuvant chemotherapy (14.5%). </p> <p><b>Primary outcomes </b> </p> <p>Our results indicate that extended PLND may reduce the risk of death from any cause over time as compared to standard PLND, but the confidence interval includes the possibility of no effect (hazard ratio [HR]: 0.78, 95% confidence interval [CI]: 0.57 to 1.07, 401 participants, low‐certainty evidence). After five years of follow‐up, this may result in 83 fewer deaths (95% CI: 174 fewer to 24 more overall deaths) per 1000 participants: 420 deaths for extended PLND compared to 503 deaths per 1000 for standard PLND. We downgraded the certainty of evidence by two levels due to study limitations and imprecision. </p> <p>Our results indicate that extended PLND may reduce the risk of death from bladder cancer over time as compared to standard PLND but, again, the confidence interval includes the possibility of no effect (HR: 0.70, 95% CI: 0.45 to 1.07, participants = 401, low‐certainty evidence). After five years of follow‐up, this corresponds to 91 fewer deaths per 1000 participants (95% CI: 176 fewer to 19 more bladder cancer deaths): 264 deaths for extended PLND compared to 355 deaths per 1000 for standard PLND. We downgraded the certainty of evidence by two levels due to study limitations and imprecision. </p> <p>Based on follow‐up of up to 30 days, we are uncertain whether extended PLND leads to more grade III‐V complications as compared to standard PLND, because of study limitations and imprecision (risk ratio [RR]: 1.13, 95% CI: 0.84 to 1.52, participants = 401, very low‐certainty evidence). </p> <p><b>Secondary outcomes </b> </p> <p>We are uncertain whether extended PLND reduces the risk of recurrence over time as compared to standard PLND, because of study limitations and imprecision (HR: 0.84, 95% CI: 0.58 to 1.22, participants = 401, very low‐certainty evidence). </p> <p>Based on follow‐up of up to 30 days, we are uncertain whether extended PLND leads to similar grade I‐II complications as compared to standard PLND because of study limitations and imprecision (RR: 0.94, 95% CI: 0.74 to 1.19, participants = 401, very low‐certainty evidence). </p> <p>We found no trials that reported on disease‐specific quality of life.</p> </section> <section id="CD013336-sec-0007"> <h3 class="title" id="CD013336-sec-0007">Authors' conclusions</h3> <p>Results from a single trial indicate that extended PLND in patients undergoing radical cystectomy for invasive urothelial carcinoma of the bladder may reduce death from any cause and death from bladder cancer over time; however, the results include the possibility of no effect. We are uncertain whether the risk of serious complications up to 30 days may be increased. We are also uncertain as to whether the risk of recurrence over time or the risk of minor complications up to 30 days changes. We were unable to conduct any of the preplanned subgroup analyses, in particular, analyses based on extended lymph node dissection templates, clinical tumor stage, and use of neoadjuvant chemotherapy that may be important effect modifiers. Important additional data is expected from a larger, ongoing trial that will also consider the role of neoadjuvant chemotherapy. Inclusion of this trial in the meta‐analysis may help address the issue of imprecision which was a common reason for downgrading the certainty of the evidence. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013336-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013336-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013336-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013336-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013336-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013336-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013336-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013336-abs-0004" lang="en"> <h3>Extended versus standard lymph node dissection in patients with bladder cancer undergoing total bladder removal </h3> <p><b>Review question</b> </p> <p>When removing the whole bladder for bladder cancer, how does removing the lymph nodes from a large area (extended lymph node dissection) compare to only from a smaller area (standard lymph node dissection)? </p> <p><b>Background</b> </p> <p>People with advanced cancer of the bladder that has spread into the deep muscle layers (but not outside the bladder) often have an operation to remove the whole bladder. As part of this operation, surgeons remove lymph nodes in that part of the body, which is an important part of the immune system. Traditionally, only the lymph nodes close to the bladder and its major blood vessels were removed. This is called a standard lymph node dissection which removes lymph nodes as high up as to where the main blood vessels for the pelvis and the leg split up. Some people think that also removing lymph nodes further away from the bladder is better in getting rid of cancer. This is called an extended lymph node dissection. It removes lymph nodes as high up as the blood vessels that supply the lower part of the intestines. We don't know whether this indeed helps people live longer and not die from bladder cancer and how the unwanted effects compare. </p> <p><b>Study characteristics</b> </p> <p>We included only studies in which chance determined whether people got a standard or extended lymph node dissection that was reported in literature up to April 29, 2019. </p> <p><b>Key results</b> </p> <p>We found only one such study that answered our review question. This study was done at 16 large hospitals in Germany and included 401 men and women with bladder cancer. </p> <p>We found that having an extended node dissection may make people less likely to die for any reason or to die from bladder cancer over time, although our confidence in this result is limited. </p> <p>We are uncertain whether an extended node dissection causes more serious unwanted effects than a standard lymph node dissection. </p> <p>We are also uncertain whether an extended node dissection makes cancer less likely to come back over time and causes a similar risk of not‐so‐serious unwanted effects compared to a standard lymph node dissection. </p> <p><b>Certainty of the evidence</b> </p> <p>The certainty of evidence for these findings was low or very low, meaning that the true outcomes may be very different from what this review found. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013336-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013336-sec-0108"></div> <h3 class="title" id="CD013336-sec-0109">Implications for practice</h3> <section id="CD013336-sec-0109"> <p>This is the first systematic review based on the only available RCT in this field. Based on the findings of this review, extended PLND may improve overall survival and cancer‐specific survival, although our results include the possibility of no effect. We are uncertain whether extended PLND results in more Clavien‐Dindo grade ≥ 3 complications for up to 30 days. We are also uncertain whether recurrence‐free survival is improved by extended PLND and whether Clavien‐Dindo grade ≤ 2 complications rates are similar to standard PLND up to 30 days. We found no evidence from the RCT for other patient‐important outcomes, such as quality of life. As a result, there is insufficient information to balance the possible advantages of extended PLND against the potential adverse effects on patients. </p> </section> <h3 class="title" id="CD013336-sec-0110">Implications for research</h3> <section id="CD013336-sec-0110"> <p>Given that the certainty of evidence for the patient‐important outcomes considered in this review was only low or very low, future studies are required. Important additional data is expected from a larger, ongoing trial (<a href="./references#CD013336-bbs2-0002" title="LernerSP , LiH , SvatekRS , KoppieTM , AlvaAS , LaRosaFG , et al. Prerandomization factors and utilization of neoadjuvant chemotherapy in a clinical trial of extended versus standard pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer. Journal of Clinical Oncology2014;32(4 suppl):295. [DOI: 10.1200/jco.2014.32.4_suppl.295] NCT01224665 . S1011 Standard or extended pelvic lymphadenectomy in treating patients undergoing surgery for invasive bladder cancer [A phase III surgical trial to evaluate the benefit of a standard versus an extended pelvic lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer]. https://clinicaltrials.gov/ct2/show/record/NCT01224665 (first received 20 October 2010). ">NCT01224665</a>) that will also consider the role of neoadjuvant chemotherapy. We expect to update this review once the result becomes available; inclusion of this trial in the meta‐analysis may help address the issue of imprecision which was a common reason for downgrading. Based on its protocol, we do not expect it to provide information on quality of life as an important secondary outcome. In the absence of additional trials, important information on treatment‐related harms, in particular, surgical complications rates of extended PLND, when performed in the community setting outside of tertiary care centers, could come from well designed, ideally prospective observational studies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013336-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013336-sec-0036"></div> <div class="table" id="CD013336-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participant or population:</b> Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)<br/> <b>Country:</b> Germany </p> <p><b>Setting:</b> Muticenter/Inpatient <br/> <b>Intervention:</b> Extended lymph node (LN) dissection<br/> <b>Comparison:</b> Standard lymph node (LN) dissection </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard LN dissection</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with Extended LN dissection</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Time to death from any cause</b> </p> <p>(absolute effect size estimates based on death rate at 5 years)<br/> follow‐up: median 43 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>HR 0.78<br/> (0.57 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>503 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83 fewer per 1,000<br/> (174 fewer to 24 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>600 per 1,000 <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89 fewer per 1,000<br/> (193 fewer to 25 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Time to death from bladder cancer</b> </p> <p>(absolute effect size estimates based on death rate at 5 years)<br/> follow‐up: median 43 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>HR 0.70<br/> (0.45 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>355 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 fewer per 1,000<br/> (176 fewer to 19 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>491 per 1,000 <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 fewer per 1,000<br/> (229 fewer to 24 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Clavien‐Dindo grade ≥ 3 complications</b><br/> assessed with: Clavien‐Dindo classification (Grade 1 to 5; high grade represents severe complication)<br/> follow‐up: 30 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.13<br/> (0.84 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 more per 1,000<br/> (46 fewer to 149 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>565 per 1,000 <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 more per 1,000<br/> (90 fewer to 294 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Time to recurrence</b> </p> <p>(absolute effect size estimates based on recurrence rate at 5 years)<br/> follow‐up: median 43 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="6" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>HR 0.84<br/> (0.58 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 fewer per 1,000<br/> (146 fewer to 64 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>453 per 1,000 <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 fewer per 1,000<br/> (158 fewer to 68 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>574 per 1,000 <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 fewer per 1,000<br/> (184 fewer to 73 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clavien‐Dindo grade ≤ 2 complications</b><sup>8</sup> <br/> assessed with: Clavien‐Dindo classification (Grade 1 to 5; high grade represents severe complication)<br/> follow‐up: 30 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94<br/> (0.74 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 fewer per 1,000<br/> (108 fewer to 79 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Disease‐specific quality of life</b><sup>9</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; <b>LN:</b> Lymph node; <b>RR:</b> Risk ratio; <b>RCT</b>: Randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: high risk of performance and detection bias </p> <p><sup>2</sup> Downgraded by one level for imprecision: confidence interval crossed the line of no difference and the assumed threshold of a clinically important difference (included benefit and no benefit) </p> <p><sup>3</sup> Baseline risk for death from any cause in the standard LN dissection group was assumed to be 60% (high risk) at 5 years as reported in <a href="./references#CD013336-bbs2-0003" title="Abd El LatifA , MiocinovicR , StephensonAJ , CampbellS , FerganyA , GongMC . Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder. Journal of Urology2012;187(Suppl 4):e707. [DOI: 10.1016/j.juro.2012.02.1768] ">Abd El‐Latif 2012</a>; observational study. </p> <p><sup>4</sup> Baseline risk for death from bladder cancer in the standard LN dissection group was assumed to be 49.1% (high risk) at 5 years as reported in <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>; observational study. </p> <p><sup>5</sup> Downgraded by two levels for imprecision: confidence interval crossed the line of no difference and the assumed threshold of a clinically important difference; wide confidence interval (included both benefit and harm) </p> <p><sup>6</sup> Baseline risk for Clavien‐Dindo grade ≥ 3 complications in the standard LN dissection group was assumed to be 56.5% (high risk) at 30 days as reported in <a href="./references#CD013336-bbs2-0008" title="BrossnerC , PychaA , TothA , MianC , KuberW . Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU International2004;93(1):64‐6. [PUBMED: 14678370] ">Brossner 2004</a>; observational study. </p> <p><sup>7</sup> Baseline risk for recurrence in the standard LN dissection group was assumed to be 45.3% (moderate risk) and 57.3% (high risk) at 5 years as reported in <a href="./references#CD013336-bbs2-0004" title="Abol‐EneinH , TilkiD , MosbahA , El‐BazM , ShokeirA , NabeehA , et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease‐free survival? A prospective single‐center study. European Urology2011;60(3):572‐7. [PUBMED: 21684070] ">Abol‐Enein 2011</a> and in <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>, respectively; both observational studies. </p> <p><sup>8</sup> We could not ascertain this outcome in observational studies </p> <p><sup>9</sup> Disease‐specific quality of life: no available data </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013336-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013336-sec-0037"></div> <section id="CD013336-sec-0038"> <h3 class="title" id="CD013336-sec-0038">Description of the condition</h3> <p>In accordance with 2018 GLOBOCAN data, urothelial carcinoma of the bladder is the 10th most common malignancy worldwide, with 549,393 new cases and 200,000 cancer‐related deaths (<a href="./references#CD013336-bbs2-0007" title="BrayF , FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians2018;68(6):394‐424. [PUBMED: 30207593] ">Bray 2018</a>). In the United States, bladder cancer comprises 5% of new cancer diagnoses and is the sixth most prevalent malignancy (<a href="./references#CD013336-bbs2-0005" title="American Cancer Society. Key statistics for bladder cancer. www.cancer.org/cancer/bladdercancer/detailedguide/bladder‐cancer‐keystatistics (accessed 7 January 2019). ">American Cancer Society</a>). </p> <p>About 90% of affected patients are older than 55 years (median age: 73 years); men are three to four times more likely than women to develop the disease according to the key statistics for bladder cancer (<a href="./references#CD013336-bbs2-0005" title="American Cancer Society. Key statistics for bladder cancer. www.cancer.org/cancer/bladdercancer/detailedguide/bladder‐cancer‐keystatistics (accessed 7 January 2019). ">American Cancer Society</a>; <a href="./references#CD013336-bbs2-0034" title="Bladder Cancer, NCCN Clinical Practice Guidelines in Oncology. www.nccn.org/professionals/physician_gls/default.aspx#site (accessed 7 January 2019), issue 1. ">NCCN Guideline 2019</a>). Approximately 75% of the newly diagnosed patients have non‐muscle invasive bladder cancer (tumor that spreads to the mucosa [carcinoma in situ, Ta] and lamina propria [stage T1]), while the remaining 25% of the patients have muscle‐invasive carcinoma (tumor invasion to the muscle layer of the bladder; stage T2) (<a href="./references#CD013336-bbs2-0010" title="BurgerM , CattoJW , DalbagniG , GrossmanHB , HerrH , KarakiewiczP , et al. Epidemiology and risk factors of urothelial bladder cancer. European Urology2013;63(2):234‐41. [PUBMED: 22877502] ">Burger 2013</a>; <a href="./references#CD013336-bbs2-0044" title="SmithAB , DealAM , WoodsME , WallenEM , PruthiRS , ChenRC , et al. Muscle‐invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU International2014;114(5):719‐26. [PUBMED: 24325202] ">Smith 2014</a>). Prognosis depends on the types of bladder cancer, with five‐year rates ranging from 96% for non‐muscle invasive bladder cancer to 5% for metastatic cases (<a href="./references#CD013336-bbs2-0034" title="Bladder Cancer, NCCN Clinical Practice Guidelines in Oncology. www.nccn.org/professionals/physician_gls/default.aspx#site (accessed 7 January 2019), issue 1. ">NCCN Guideline 2019</a>). An estimated 17,240 deaths were caused by bladder cancer in the US in 2018 (<a href="./references#CD013336-bbs2-0005" title="American Cancer Society. Key statistics for bladder cancer. www.cancer.org/cancer/bladdercancer/detailedguide/bladder‐cancer‐keystatistics (accessed 7 January 2019). ">American Cancer Society</a>). </p> <p>Risk factors for urothelial bladder cancer vary (<a href="./references#CD013336-bbs2-0010" title="BurgerM , CattoJW , DalbagniG , GrossmanHB , HerrH , KarakiewiczP , et al. Epidemiology and risk factors of urothelial bladder cancer. European Urology2013;63(2):234‐41. [PUBMED: 22877502] ">Burger 2013</a>; <a href="./references#CD013336-bbs2-0011" title="ChangSS , BochnerBH , ChouR , DreicerR , KamatAM , LernerSP , et al. Treatment of non‐metastatic muscle‐Invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. Journal of Urology2017;198(3):552‐9. [PUBMED: 28456635] ">Chang 2017</a>; <a href="./references#CD013336-bbs2-0014" title="European Association of Urology. Muscle‐invasive and metastatic bladder cancer. uroweb.org/guideline/bladder‐cancer‐muscle‐invasive‐and‐metastatic/ (accessed 7 January 2019). ">EAU Guideline 2018</a>). Smoking and occupational exposure to chemicals are well‐known environmental risk factors. With regard to medical conditions, radiotherapy for other malignancies of pelvic organs and chronic urinary tract infections are strongly related to the development of bladder cancer. Other controversial risk factors are dietary factors, gender, race, and socioeconomic status (<a href="./references#CD013336-bbs2-0010" title="BurgerM , CattoJW , DalbagniG , GrossmanHB , HerrH , KarakiewiczP , et al. Epidemiology and risk factors of urothelial bladder cancer. European Urology2013;63(2):234‐41. [PUBMED: 22877502] ">Burger 2013</a>; <a href="./references#CD013336-bbs2-0011" title="ChangSS , BochnerBH , ChouR , DreicerR , KamatAM , LernerSP , et al. Treatment of non‐metastatic muscle‐Invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. Journal of Urology2017;198(3):552‐9. [PUBMED: 28456635] ">Chang 2017</a>; <a href="./references#CD013336-bbs2-0014" title="European Association of Urology. Muscle‐invasive and metastatic bladder cancer. uroweb.org/guideline/bladder‐cancer‐muscle‐invasive‐and‐metastatic/ (accessed 7 January 2019). ">EAU Guideline 2018</a>). Genetic instability may also be implicated in the genesis of bladder cancer (<a href="./references#CD013336-bbs2-0011" title="ChangSS , BochnerBH , ChouR , DreicerR , KamatAM , LernerSP , et al. Treatment of non‐metastatic muscle‐Invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. Journal of Urology2017;198(3):552‐9. [PUBMED: 28456635] ">Chang 2017</a>; <a href="./references#CD013336-bbs2-0015" title="FigueroaJD , YeY , SiddiqA , Garcia‐ClosasM , ChatterjeeN , Prokunina‐OlssonL , et al. Genome‐wide association study identifies multiple loci associated with bladder cancer risk. Human Molecular Genetics2014;23(5):1387‐98. [PUBMED: 24163127] ">Figueroa 2014</a>). </p> </section> <section id="CD013336-sec-0039"> <h3 class="title" id="CD013336-sec-0039">Description of the intervention</h3> <p>Lymph node dissection (LND) is a surgical procedure in which the lymph nodes in the tumor area or in the whole lymphatic drainage area are also removed in addition to surgical management of primary cancer. Radical cystectomy (RC) (removal of the bladder) with bilateral pelvic lymph node dissection (PLND) and cisplatin‐based neoadjuvant or adjuvant chemotherapy is the gold standard for the management of resectable (able to be removed by surgery) non‐metastatic muscle‐invasive bladder cancer and for non‐muscle‐invasive high grade urothelial carcinoma that is refractory to intravesical therapy (<a href="./references#CD013336-bbs2-0011" title="ChangSS , BochnerBH , ChouR , DreicerR , KamatAM , LernerSP , et al. Treatment of non‐metastatic muscle‐Invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. Journal of Urology2017;198(3):552‐9. [PUBMED: 28456635] ">Chang 2017</a>; <a href="./references#CD013336-bbs2-0014" title="European Association of Urology. Muscle‐invasive and metastatic bladder cancer. uroweb.org/guideline/bladder‐cancer‐muscle‐invasive‐and‐metastatic/ (accessed 7 January 2019). ">EAU Guideline 2018</a>; <a href="./references#CD013336-bbs2-0020" title="HerrHW , SoganiPC . Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. Journal of Urology2001;166(4):1296‐9. [PUBMED: 11547061] ">Herr 2001</a>; <a href="./references#CD013336-bbs2-0034" title="Bladder Cancer, NCCN Clinical Practice Guidelines in Oncology. www.nccn.org/professionals/physician_gls/default.aspx#site (accessed 7 January 2019), issue 1. ">NCCN Guideline 2019</a>; <a href="./references#CD013336-bbs2-0045" title="SteinJP , LieskovskyG , CoteR , GroshenS , FengAC , BoydS , et al. Radical cystectomy in the treatment of invasive bladder cancer: long‐term results in 1,054 patients. Journal of Clinical Oncology2001;19(3):666‐75. [PUBMED: 11157016] ">Stein 2001</a>; <a href="./references#CD013336-bbs2-0042" title="ShabsighA , KoretsR , VoraKC , BrooksCM , CroninAM , SavageC , et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. European Urology2009;55(1):164‐74. [PUBMED: 18675501] ">Shabsigh 2009</a>). The suggested PLND templates for their treatment are as follows: </p> <p> <ul id="CD013336-list-0001"> <li> <p>Limited PLND: removal of lymph nodes limited to obturator or peri‐vesical fossa, lying laterally by the external iliac vein and are present medial to the obturator nerve (<a href="./references#CD013336-bbs2-0008" title="BrossnerC , PychaA , TothA , MianC , KuberW . Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU International2004;93(1):64‐6. [PUBMED: 14678370] ">Brossner 2004</a>; <a href="./references#CD013336-bbs2-0025" title="HolmerM , BendahlPO , DavidssonT , GudjonssonS , ManssonW , LiedbergF . Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?. World Journal of Urology2009;27(4):521‐6. [PUBMED: 19145436] ">Holmer 2009</a>; <a href="./references#CD013336-bbs2-0026" title="HoriJ , TamakiG , KitaM , IwataS , MatsumotoS , KakizakiH . Survival impact of the extent of pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer. European Journal of Cancer2013;49:S16. [DOI: 10.1016/S0959‐8049(13)70039‐X] ">Hori 2013</a>) </p> </li> <li> <p>Standard PLND: removal of lymph nodes, along with the obturator and external, internal, and common iliac nodes up to the crossing of the ureter (<a href="./references#CD013336-bbs2-0011" title="ChangSS , BochnerBH , ChouR , DreicerR , KamatAM , LernerSP , et al. Treatment of non‐metastatic muscle‐Invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. Journal of Urology2017;198(3):552‐9. [PUBMED: 28456635] ">Chang 2017</a>; <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>) </p> </li> <li> <p>Extended PLND: removal of lymph nodes, along with the aortic bifurcation and common iliac vessels, the genitofemoral nerve, the circumflex iliac vein and lymph node of Cloquet, and the internal iliac vessels (<a href="./references#CD013336-bbs2-0025" title="HolmerM , BendahlPO , DavidssonT , GudjonssonS , ManssonW , LiedbergF . Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?. World Journal of Urology2009;27(4):521‐6. [PUBMED: 19145436] ">Holmer 2009</a>; <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>). </p> </li> <li> <p>Super‐extended PLND: LND is performed up to the inferior mesenteric artery with a template of extended PLND (<a href="./references#CD013336-bbs2-0004" title="Abol‐EneinH , TilkiD , MosbahA , El‐BazM , ShokeirA , NabeehA , et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease‐free survival? A prospective single‐center study. European Urology2011;60(3):572‐7. [PUBMED: 21684070] ">Abol‐Enein 2011</a>). </p> </li> </ul> </p> <p>In this review, standard PLND refers to limited and standard PLND as defined above, and extended PLND refers to any template beyond the standard PLND. </p> <section id="CD013336-sec-0040"> <h4 class="title">Adverse events associated with the intervention</h4> <p>There are several complications inherent to PLND, including ureteral injury, major vascular injury, obturator nerve injury, pelvic lymphocele (a collection of lymphatic fluid not bordered by epithelial lining), deep venous thrombosis, and leg/scrotal edema (<a href="./references#CD013336-bbs2-0027" title="KavoussiLR , SosaE , ChandhokeP , ChodakG , ClaymanRV , HadleyHR , et al. Complications of laparoscopic pelvic lymph node dissection. Journal of Urology1993;149(2):322‐5. [PUBMED: 8426411] ">Kavoussi 1993</a>). A large retrospective study reported 28% early complications and 2.6%‐3% perioperative mortality rates for PLND (<a href="./references#CD013336-bbs2-0045" title="SteinJP , LieskovskyG , CoteR , GroshenS , FengAC , BoydS , et al. Radical cystectomy in the treatment of invasive bladder cancer: long‐term results in 1,054 patients. Journal of Clinical Oncology2001;19(3):666‐75. [PUBMED: 11157016] ">Stein 2001</a>). However, when comparing complication rates according to the extent of PLND (i.e. extended versus standard or limited PLND) and age (octogenarians versus non‐octogenarians), no detectable differences were reported except for prolonged operation time in extended PLND performed laparoscopically (<a href="./references#CD013336-bbs2-0008" title="BrossnerC , PychaA , TothA , MianC , KuberW . Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU International2004;93(1):64‐6. [PUBMED: 14678370] ">Brossner 2004</a>; <a href="./references#CD013336-bbs2-0016" title="FinelliA , GillIS , DesaiMM , MoinzadehA , Magi‐GalluzziC , KaoukJH . Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. Journal of Urology2004;172(5 Pt 1):1809‐12. [PUBMED: 15540725] ">Finelli 2004</a>; <a href="./references#CD013336-bbs2-0017" title="GrabbertM , GrimmT , BuchnerA , KretschmerA , ApfelbeckM , SchulzG , et al. Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder. International Urology and Nephrology2017;49(12):2137‐42. [PUBMED: 28900840] ">Grabbert 2017</a>; <a href="./references#CD013336-bbs2-0025" title="HolmerM , BendahlPO , DavidssonT , GudjonssonS , ManssonW , LiedbergF . Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?. World Journal of Urology2009;27(4):521‐6. [PUBMED: 19145436] ">Holmer 2009</a>; <a href="./references#CD013336-bbs2-0038" title="PoulsenAL , HornT , StevenK . Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. Journal of Urology1998;160(6 Pt 1):2015‐20. [PUBMED: 9817313] ">Poulsen 1998</a>). Moreover, a prospective multicenter study reported no significant adverse events to be associated with extended PNLD (<a href="./references#CD013336-bbs2-0031" title="LeissnerJ , GhoneimMA , Abol‐EneinH , ThuroffJW , FranzaringL , FischM , et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. Journal of Urology2004;171(1):139‐44. [PUBMED: 14665862] ">Leissner 2004</a>). </p> </section> </section> <section id="CD013336-sec-0041"> <h3 class="title" id="CD013336-sec-0041">How the intervention might work</h3> <p>The incidence of lymph node metastasis at RC for bladder cancer ranges from 13% to 26% and is associated with a high risk of tumor recurrence and progression (<a href="./references#CD013336-bbs2-0031" title="LeissnerJ , GhoneimMA , Abol‐EneinH , ThuroffJW , FranzaringL , FischM , et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. Journal of Urology2004;171(1):139‐44. [PUBMED: 14665862] ">Leissner 2004</a>; <a href="./references#CD013336-bbs2-0038" title="PoulsenAL , HornT , StevenK . Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. Journal of Urology1998;160(6 Pt 1):2015‐20. [PUBMED: 9817313] ">Poulsen 1998</a>; <a href="./references#CD013336-bbs2-0045" title="SteinJP , LieskovskyG , CoteR , GroshenS , FengAC , BoydS , et al. Radical cystectomy in the treatment of invasive bladder cancer: long‐term results in 1,054 patients. Journal of Clinical Oncology2001;19(3):666‐75. [PUBMED: 11157016] ">Stein 2001</a>). PLND potentially has therapeutic importance by removing undetected metastatic lymph nodes, and thus, for providing a chance of cure for some patients for whom radical cystectomy alone would have been insufficient. Furthermore, lymph node dissection is important for accurate pathological staging and helps stratify the risk, therefore, helping determine the need for adjuvant systemic chemotherapy after RC (<a href="./references#CD013336-bbs2-0029" title="KuJH . Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review. Korean Journal of Urology2010;51(6):371‐8. [PUBMED: 20577602] ">Ku 2010</a>; <a href="./references#CD013336-bbs2-0051" title="YoussefRF , RajGV . Lymphadenectomy in management of invasive bladder cancer. International Journal of Surgical Oncology2011;2011:758189. [PUBMED: 22312522] ">Youssef 2011</a>). </p> <p>Extended PLND also captures lymph node metastases beyond the common iliac bifurcation yielding an ever larger number of nodes (<a href="./references#CD013336-bbs2-0049" title="VazinaA , DugiD , ShariatSF , EvansJ , LinkR , LernerSP . Stage specific lymph node metastasis mapping in radical cystectomy specimens. Journal of Urology2004;171(5):1830‐4. [PUBMED: 15076287] ">Vazina 2004</a>). Removing more lymph nodes is hypothesized to reduce the incidence of recurrence and potentially provide better recurrence‐free, cancer‐specific, and overall survival (<a href="./references#CD013336-bbs2-0021" title="HerrHW , BochnerBH , DalbagniG , DonatSM , ReuterVE , BajorinDF . Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. Journal of Urology2002;167(3):1295‐8. [PUBMED: 11832716] ">Herr 2002</a>; <a href="./references#CD013336-bbs2-0028" title="KonetyBR , JoslynSA , O'DonnellMA . Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. Journal of Urology2003;169(3):946‐50. [PUBMED: 12576819] ">Konety 2003</a>; <a href="./references#CD013336-bbs2-0030" title="LeissnerJ , HohenfellnerR , ThuroffJW , WolfHK . Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU International2000;85(7):817‐23. [PUBMED: 10792159] ">Leissner 2000</a>; <a href="./references#CD013336-bbs2-0046" title="StevenK , PoulsenAL . Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. Journal of Urology2007;178(4 Pt 1):1218‐23; discussion 1223‐4. [PUBMED: 17698113] ">Steven 2007</a>). </p> </section> <section id="CD013336-sec-0042"> <h3 class="title" id="CD013336-sec-0042">Why it is important to do this review</h3> <p>Until recently, the evidence for the benefits and harms of extended PLND over those of standard PLND originated only from nonrandomized trials (<a href="./references#CD013336-bbs2-0003" title="Abd El LatifA , MiocinovicR , StephensonAJ , CampbellS , FerganyA , GongMC . Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder. Journal of Urology2012;187(Suppl 4):e707. [DOI: 10.1016/j.juro.2012.02.1768] ">Abd El‐Latif 2012</a>; <a href="./references#CD013336-bbs2-0004" title="Abol‐EneinH , TilkiD , MosbahA , El‐BazM , ShokeirA , NabeehA , et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease‐free survival? A prospective single‐center study. European Urology2011;60(3):572‐7. [PUBMED: 21684070] ">Abol‐Enein 2011</a>; <a href="./references#CD013336-bbs2-0008" title="BrossnerC , PychaA , TothA , MianC , KuberW . Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU International2004;93(1):64‐6. [PUBMED: 14678370] ">Brossner 2004</a>; <a href="./references#CD013336-bbs2-0029" title="KuJH . Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review. Korean Journal of Urology2010;51(6):371‐8. [PUBMED: 20577602] ">Ku 2010</a>; <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>; <a href="./references#CD013336-bbs2-0050" title="WangG . Clinical significance of radical cystectomy with extended lymphadenectomy and influencing factors associated with recurrence of bladder cancer. Journal of Endourology2013;27(S1):A142. [DOI: 10.1089/end.2013.2001] ">Wang 2013</a>) which had many inherent limitations. Systematic reviews and meta‐analyses based on these studies have been plagued by the same limitations (<a href="./references#CD013336-bbs2-0006" title="BiL , HuangH , FanX , LiK , XuK , JiangC , et al. Extended vs non‐extended pelvic lymph node dissection and their influence on recurrence‐free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta‐analysis of comparative studies. BJU International2014;113(5b):E39‐48. [PUBMED: 24053715] ">Bi 2014</a>; <a href="./references#CD013336-bbs2-0009" title="BruinsHM , VeskimaeE , HernandezV , ImamuraM , NeubergerMM , DahmP , et al. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. European Urology2014;66(6):1065‐77. [PUBMED: 25074764] ">Bruins 2014</a>; <a href="./references#CD013336-bbs2-0036" title="PalmerD , ClubbA , DuboyAJ , NeubergerMM , GilbertSM , DahmP . The therapeutic benefit of an extended lymph node dissection in radical cystectomy: a systematic review and meta‐analysis of observational studies applying the novel Cochrane risk of bias tool. Journal of Urology2011;185(4):e742. [DOI: 10.1016/j.juro.2011.02.1883] ">Palmer 2011</a>; <a href="./references#CD013336-bbs2-0048" title="TilkiD , BrausiM , ColomboR , EvansCP , FradetY , FritscheHM , et al. Lymphadenectomy for bladder cancer at the time of radical cystectomy. European Urology2013;64(2):266‐76. [PUBMED: 23648149] ">Tilki 2013</a>). </p> <p>This Cochrane review was triggered by the publication of the first randomized controlled trial on this topic. In contrast to prior systematic reviews, this review stands out for its rigorous methodology which includes a registered protocol, a comprehensive search, a focus on patient‐important outcomes and the application of GRADE. We expect this review to be helpful to clinicians, guideline developers, and policy‐makers in helping them establish an evidence‐based role for extended PLND when treating muscle‐invasive bladder cancer. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013336-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013336-sec-0043"></div> <p>To assess the effects of extended versus standard PLND in patients undergoing cystectomy to treat muscle‐invasive (cT2 and cT3) and treatment refractory, non‐muscle‐invasive (cT1 with or without carcinoma in situ) urothelial carcinoma of the bladder. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013336-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013336-sec-0044"></div> <section id="CD013336-sec-0045"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013336-sec-0046"> <h4 class="title">Types of studies</h4> <p>This review is based on a previously published protocol (<a href="./references#CD013336-bbs2-0052" title="HwangEC , SathianathenNJ , ImamuraM , KuntzGM , RiskMC , DahmP . Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy. www.crd.york.ac.uk/prospero/ (accessed 18 December 2018). ">CRD42018116290</a>). For details on the differences between the previous protocol and the method followed here, please refer to the '<a href="#CD013336-sec-0121">Differences between protocol and review</a>' section. We included randomized controlled trials (RCTs) as they offer more reliable results. We excluded quasi‐randomized and nonrandomized studies, cohort studies, case series, cross‐over trials, and cluster‐randomized trials. We did not exclude studies on the basis of publication status or language. </p> </section> <section id="CD013336-sec-0047"> <h4 class="title">Types of participants</h4> <p>We included studies of participants with urothelial carcinoma of the bladder undergoing RC with PLND with curative intent. Participants of these trials underwent histological confirmation of urothelial carcinoma based on transurethral resection of the bladder (TURBT) and cross‐sectional imaging (usually computer tomography (CT) and/or magnetic resonance imaging (MRI) indicating clinically localized disease with or without suspected locoregional lymphatic spread (N0 or N1) but without distant metastases (M0). Eligible clinical tumor stages were T2 and T3, as well as treatment‐refractory T1 and carcinoma in situ. We excluded trials of participants with locally advanced, but unresectable, bladder urothelial carcinoma with pelvic fixation (clinical stage T4) </p> </section> <section id="CD013336-sec-0048"> <h4 class="title">Types of interventions</h4> <p>We planned to investigate the following experimental and comparator interventions.</p> <section id="CD013336-sec-0049"> <h5 class="title">Experimental interventions</h5> <p>We planned to include studies that had used templates for extended PLND that varied somewhat due to the lack of a gold standard. </p> <p> <ul id="CD013336-list-0002"> <li> <p>Extended PLND</p> <ul id="CD013336-list-0003"> <li> <p>Anatomical boundaries</p> <ul id="CD013336-list-0004"> <li> <p>cranial: inferior mesenteric artery, caudal: pelvic floor (circumflex iliac vein), both lateral: genitofemoral nerve, both medial: ureter, dorsal: rectum, or </p> </li> <li> <p>anything beyond boundaries of the comparator</p> </li> </ul> </li> </ul> </li> </ul> </p> </section> <section id="CD013336-sec-0050"> <h5 class="title">Comparator interventions</h5> <p> <ul id="CD013336-list-0005"> <li> <p>Standard PLND</p> <ul id="CD013336-list-0006"> <li> <p>Anatomical boundaries</p> <ul id="CD013336-list-0007"> <li> <p>cranial: common iliac bifurcation (bifurcation of the internal and external iliac artery), caudal: pelvic floor (circumflex iliac vein), both lateral: genitofemoral nerve, both medial: ureter, dorsal: obturator nerve </p> </li> </ul> </li> </ul> </li> </ul> </p> <p>Concomitant interventions had to be the same in the experimental and comparator groups to ensure fair comparisons. </p> </section> </section> <section id="CD013336-sec-0051"> <h4 class="title">Types of outcome measures</h4> <p>We did not exclude trials if they met inclusion criteria but did not report one or several of our primary or secondary outcomes. </p> <section id="CD013336-sec-0052"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013336-list-0008"> <li> <p>Time to death from any cause (overall survival, time‐to‐event outcome)</p> </li> <li> <p>Time to death from bladder cancer (disease‐specific survival, time‐to‐event outcome)</p> </li> <li> <p>Clavien‐Dindo III‐V complications (dichotomous outcome)</p> </li> </ul> </p> </section> <section id="CD013336-sec-0053"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013336-list-0009"> <li> <p>Time to recurrence (recurrence‐free survival, time‐to‐event outcome)</p> </li> <li> <p>Clavien‐Dindo I‐II complications (dichotomous outcome)</p> </li> <li> <p>Disease‐specific quality of life (continuous outcome)</p> </li> </ul> </p> <section id="CD013336-sec-0054"> <h6 class="title">Method and timing for outcome measures</h6> <p> <ul id="CD013336-list-0010"> <li> <p>Time to death from any cause: as measured from the time of randomization to the time of death due to any cause </p> </li> <li> <p>Time to death from bladder cancer: as measured from the time of randomization to the time of death due to bladder cancer </p> </li> <li> <p>Time to recurrence: as measured from the time of randomization to the time of the first confirmed recurrence </p> <ul id="CD013336-list-0011"> <li> <p>Definition of recurrence: judged based on the imaging, such as computed tomography, with or without biopsy </p> </li> </ul> </li> <li> <p>Clavien‐Dindo I‐V complications: we used the Clavien‐Dindo classification system to assess surgical complications (<a href="./references#CD013336-bbs2-0012" title="DindoD , DemartinesN , ClavienPA . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery2004;240(2):205‐13. [PUBMED: 15273542] ">Dindo 2004</a>). If an eligible study’s authors had not used the Clavien‐Dindo system, we judged the adverse events by severity using the information available in the studies </p> </li> <li> <p>Disease‐specific quality of life: measured by validated instruments (e.g. the 12‐item Short Form (SF‐12), 36‐item Short Form (SF‐36), Functional Assessment of Cancer Therapy (FACT) questionnaire, or EORTC Quality of Life Questionnaire version 3.0 </p> </li> </ul> </p> <p>We considered complications that appeared within six months after the randomization. If we were unable to retrieve the information required to assess time‐to‐event outcomes, we tried to assess the number of events per the total number of participants included in each relevant study for dichotomized outcomes at 12, 24, 36, and 60 months for death from any cause, death from bladder cancer, and recurrence. </p> </section> </section> </section> </section> <section id="CD013336-sec-0055"> <h3 class="title">Search methods for identification of studies</h3> <p>We performed a comprehensive literature search with no restrictions on language or the status of publication. We planned to re‐run searches within three months prior to the anticipated publication of the review, should the original search date have fallen outside of this timeframe. </p> <section id="CD013336-sec-0056"> <h4 class="title">Electronic searches</h4> <p>We searched the following sources for relevant literature that was published since the inception of each database (<a href="./appendices#CD013336-sec-0114">Appendix 1</a>). The date of the last search for all databases was April 29, 2019. </p> <p> <ul id="CD013336-list-0012"> <li> <p>PubMed (late 1940s ‐ present);</p> </li> <li> <p>Embase (Elsevier, 1947 ‐ present);</p> </li> <li> <p>Cochrane Controlled Trials (Issue 4, April 2019);</p> </li> <li> <p>Web of Science (1900 ‐ 2019);</p> </li> <li> <p>LILACS (Latin American and the Caribbean Health Sciences Literature; <a href="http://lilacs.bvsalud.org/en/" target="_blank">http://lilacs.bvsalud.org/en/</a>). </p> </li> </ul> </p> <p>We also searched the following:</p> <p> <ul id="CD013336-list-0013"> <li> <p>ClinicalTrials.gov (<a href="https://www.clinicaltrials.gov/" target="_blank">https://www.clinicaltrials.gov/</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform search portal (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>). </p> </li> </ul> </p> <p>If we detected any additional relevant keywords during our literature search, we modified our electronic search strategies to incorporate these terms and documented the changes. </p> </section> <section id="CD013336-sec-0057"> <h4 class="title">Searching other resources</h4> <p>We tried to identify other potentially eligible trials or ancillary publications by searching the reference lists of included trials, reviews, and meta‐analyses. We also contacted the authors of trials included in this review to identify any further studies that we may have missed. We also searched the meeting proceedings of the American Urological Association, European Association of Urology, and American Society of Clinical Oncology annual meetings for the last three years (2016 to 2018) for relevant abstracts of unpublished studies. </p> </section> </section> <section id="CD013336-sec-0058"> <h3 class="title" id="CD013336-sec-0058">Data collection and analysis</h3> <p>In this review, we followed the methodological recommendations provided by the Cochrane Handbook (<a href="./references#CD013336-bbs2-0023" title="HigginsJPT , ChurchillR , ChandlerJ , Cumpston MS(editors) . Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017a</a>). </p> <section id="CD013336-sec-0059"> <h4 class="title">Selection of studies</h4> <p>Two review authors (ECH and NS) independently assessed abstracts and titles to determine which studies should be assessed further using the Covidence software. They investigated all potentially relevant records, such as full texts and mapped records to studies, and classified them as studies that should be included, excluded, await classification, or as ongoing studies in accordance with the criteria provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013336-bbs2-0023" title="HigginsJPT , ChurchillR , ChandlerJ , Cumpston MS(editors) . Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017a</a>). We resolved any discrepancies through consensus or by recourse to a third review author (PD). If a resolution was not possible, we designated the study as 'awaiting classification'. We documented the reasons for the exclusion of studies in the 'Characteristics of excluded studies' table. We presented an adapted PRISMA flow diagram showing the process of study selection (<a href="./references#CD013336-bbs2-0032" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GotzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Medicine2009;6(7):e1000100. [PUBMED: 19621070] ">Liberati 2009</a>) (<a href="#CD013336-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD013336-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013336-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD013336-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>In this review, two authors (ECH and NS) independently extracted relevant data using a data extraction form. We based this form on the recommendations of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013336-bbs2-0023" title="HigginsJPT , ChurchillR , ChandlerJ , Cumpston MS(editors) . Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017a</a>) and pilot‐tested it before using it in our analysis. These authors resolved any potential disagreements by consensus or through discussion with a third author (PD). In addition, when necessary, we contacted the original authors of a given study. We collected and used the most detailed numerical data that might facilitate similar analyses of included studies. We have presented all characteristics of the included studies in the ‘<a href="./references#CD013336-sec-0124" title="">Characteristics of included studies</a>’ table. </p> <p> <ul id="CD013336-list-0014"> <li> <p>Record citation (e.g. authors’ names and article title).</p> </li> <li> <p>Details of methods: study design and date when the study was conducted.</p> </li> <li> <p>Details of participants: setting; country; the number of included participants; age; sex; inclusion and exclusion criteria; tumor stage (clinical or pathologic T category); pathologic nodal stage; positive surgical margin; neo‐ or adjuvant chemotherapy. </p> </li> <li> <p>Details of interventions: the number of participants randomly assigned to each intervention group and PLND boundaries in each group. </p> </li> <li> <p>Details of outcomes: outcomes included in this review that were assessed in each study, including how each was measured and the times at which they were measured. </p> </li> <li> <p>Funding sources for the study.</p> </li> <li> <p>Declarations of interest among the primary study authors.</p> </li> </ul> </p> <section id="CD013336-sec-0061"> <h5 class="title">Dealing with duplicate and companion publications</h5> <p>In the event of duplicate publications, companion documents, or multiple reports for a primary study, we maximized the yield of information by mapping all publications to unique studies and collating all available data. We used the most complete data set aggregated across all known publications. In case of doubt, we prioritized the publication that had reported the longest follow‐up associated with our primary or secondary outcomes. </p> </section> </section> <section id="CD013336-sec-0062"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (ECH and NS) independently assessed the risks of bias for each included study. We resolved the disagreements by consensus or by consulting with a third author (PD). We used the Cochrane “Risk of bias” assessment tool for the following domains (<a href="./references#CD013336-bbs2-0024" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017b</a>). </p> <p> <ul id="CD013336-list-0015"> <li> <p>Random sequence generation (selection bias);</p> </li> <li> <p>Allocation concealment (selection bias);</p> </li> <li> <p>Blinding of participants and personnel (performance bias);</p> </li> <li> <p>Blinding of outcome assessments (detection bias);</p> </li> <li> <p>Incomplete outcome data (attrition bias);</p> </li> <li> <p>Selective reporting (reporting bias);</p> </li> <li> <p>Other potential sources of bias (e.g. baseline imbalance).</p> </li> </ul> </p> <p>We judged the risk of bias by categorizing them into domains, such as “low risk,” “high risk,” or “unclear risk.” We presented the results of this assessment graphically. For selection bias and reporting bias, we evaluated the risks of bias at the trial level. </p> <p>For performance bias (blinding of participants and personnel), we defined all outcomes as similarly susceptible to performance bias and assessed them in one group. </p> <p>For detection bias (blinding of outcome assessments), we grouped outcomes as susceptible to detection bias (subjective) or not susceptible to detection bias (objective) outcomes. We defined the following outcome measures as subjective: </p> <p> <ul id="CD013336-list-0016"> <li> <p>time to death from bladder cancer;</p> </li> <li> <p>time to recurrence;</p> </li> <li> <p>Clavien‐Dindo I‐II complications;</p> </li> <li> <p>disease‐specific quality of life.</p> </li> </ul> </p> <p>We defined the following outcomes as objective:</p> <p> <ul id="CD013336-list-0017"> <li> <p>time to death from any cause;</p> </li> <li> <p>Clavien‐Dindo III‐V complications.</p> </li> </ul> </p> <p>We assessed attrition bias (incomplete outcome data) from an outcome‐specific perspective. We summarized the risk of attrition bias across domains for each outcome in each included study, as well as across the studies and domains for each outcome. This was done in accordance with the approach for summary assessment of the risk of bias presented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013336-bbs2-0024" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017b</a>). </p> </section> <section id="CD013336-sec-0063"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed dichotomous data as RRs with a 95% confidence interval (CI). For continuous outcomes measured on the same scale, we estimated the intervention effect using the mean difference (MD) with a 95% CI. For continuous outcomes that measured the same underlying concept (e.g. disease‐specific quality of life), but on different measurement scales, we calculated the standardized mean difference (SMD). We expressed time‐to‐event data as HRs with 95% CI or used an indirect estimation method if HRs were not given (<a href="./references#CD013336-bbs2-0037" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. [PUBMED: 9921604] ">Parmar 1998</a>; <a href="./references#CD013336-bbs2-0047" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8:16. [PUBMED: 17555582] ">Tierney 2007</a>). </p> </section> <section id="CD013336-sec-0064"> <h4 class="title">Unit of analysis issues</h4> <p>The units of analysis were each individual participant. If we had identified trials with more than two intervention groups for inclusion in this review, we handled these in accordance with the guidance provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013336-bbs2-0022" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) , Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD013336-sec-0065"> <h4 class="title">Dealing with missing data</h4> <p>We planned to obtain missing data from the original authors of each study included here, if feasible; we further planned to perform intention‐to‐treat analyses if data were available. Otherwise, we performed available‐case analyses. We investigated attrition rates (e.g. dropouts, losses to follow‐up, and withdrawals) and critically appraised any issues of missing data. We did not plan to impute missing data. </p> </section> <section id="CD013336-sec-0066"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess heterogeneity. However, we included only one RCT and, therefore, the assessment of heterogeneity was not possible. </p> </section> <section id="CD013336-sec-0067"> <h4 class="title">Assessment of reporting biases</h4> <p>We tried to obtain study protocols to assess selective outcome reporting. As we included only one study, we could not use funnel plots to assess small study effects. </p> </section> <section id="CD013336-sec-0068"> <h4 class="title">Data synthesis</h4> <p>As we included only one RCT, we only re‐analyzed and reported single study data using Review Manager 5 software (<a href="./references#CD013336-bbs2-0040" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>) in accordance with the guidelines contained in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013336-bbs2-0023" title="HigginsJPT , ChurchillR , ChandlerJ , Cumpston MS(editors) . Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017a</a>). </p> </section> <section id="CD013336-sec-0069"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We expected the following characteristics to introduce clinical heterogeneity and planned to carry out subgroup analyses to investigate interactions. </p> <p> <ul id="CD013336-list-0018"> <li> <p>Extended PLND template (if different PLND templates were used in various studies);</p> </li> <li> <p>Clinical tumor stage (non‐muscle invasive [e.g., T1G3] versus muscle‐invasive disease [e.g. ≥ T2]); </p> </li> <li> <p>Neoadjuvant chemotherapy (neoadjuvant versus no neoadjuvant chemotherapy).</p> </li> </ul> </p> <p>We restricted subgroup analyses to the primary outcomes only.</p> </section> <section id="CD013336-sec-0070"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses in order to explore the influence of the following factors on effect size, if applicable: </p> <p> <ul id="CD013336-list-0019"> <li> <p>Restricting the analysis by taking the risk of bias into account and excluding studies classified as having a high or unclear risk of bias. </p> </li> </ul> </p> <p>However, we could not perform any subgroup or sensitivity analyses due to the lack of relevant data. </p> <section id="CD013336-sec-0071"> <h5 class="title"><i>'Summary of findings' table</i> </h5> <section id="CD013336-sec-0072"> <h6 class="title">Main outcomes for the 'Summary of findings' table</h6> <p>We present a '<a href="./full#CD013336-tbl-0001">summary of findings Table for the main comparison</a>' that reports on the following measures of outcome listed according to priority. One review author (PD) determined the priorities of the measures of outcome using content expertise: </p> <p> <ul id="CD013336-list-0020"> <li> <p>Time to death from any cause;</p> </li> <li> <p>Time to death from bladder cancer;</p> </li> <li> <p>Clavien‐Dindo III‐V complications;</p> </li> <li> <p>Time to recurrence;</p> </li> <li> <p>Clavien‐Dindo I‐II complications;</p> </li> <li> <p>Disease‐specific quality of life.</p> </li> </ul> </p> <p>We presented the findings and the certainty of the available evidence according to the GRADE methodology (<a href="./references#CD013336-bbs2-0041" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , AklE , et al. Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017</a>). </p> <p>We assessed the overall certainty of evidence for each outcome according to the GRADE approach, which considers five criteria that are related not only to internal validity (risk of bias, inconsistency, imprecision, and publication bias) but also to external validity (the directness of results) (<a href="./references#CD013336-bbs2-0018" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians?. BMJ2008;336(7651):995‐8. [PUBMED: 18456631] '>Guyatt 2008</a>). Two authors (ECH, NS) of this review independently rated the certainty of evidence for each outcome as "high", "moderate", "low", or "very low". We resolved discrepancies by consensus or, if needed, by the arbitration of a third author (PD). We presented a summary of the evidence for the main outcomes in the 'Summary of findings' table, which we generated using the Gradepro GDT (<a href="https://gradepro.org/" target="_blank">https://gradepro.org/</a>). This table provides key information about the best estimate of the magnitude of an effect in relative terms and presents absolute differences for each relevant comparison of alternative management strategies, numbers of participants and studies addressing each important outcome, as well as the rating of our overall confidence in the effect estimates for each outcome (<a href="./references#CD013336-bbs2-0019" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [PUBMED: 21195583] ">Guyatt 2011</a>; <a href="./references#CD013336-bbs2-0041" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , AklE , et al. Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017</a>). </p> </section> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013336-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013336-sec-0073"></div> <section id="CD013336-sec-0074"> <h3 class="title">Description of studies</h3> <section id="CD013336-sec-0075"> <h4 class="title">Results of the search</h4> <p>Our literature search yielded 774 references to which we added an additional 15 records that were identified by searching trial registries and manual searches. After the exclusion of duplicates, we screened 677 references at the title and abstract stage. Of these 677 references, five references that were mapped to two unique studies entered the full‐text screening stage. We ultimately included one study in the qualitative analyses (<a href="#CD013336-fig-0001">Figure 1</a>). </p> </section> <section id="CD013336-sec-0076"> <h4 class="title">Included studies</h4> <section id="CD013336-sec-0077"> <h5 class="title">Source of data</h5> <p>We identified one RCT (<a href="./references#CD013336-bbs2-0001" title="GschwendJE , HeckMM , LehmannJ , RuebbenH , AlbersP , HeidenreichA , et al. Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: survival results from a prospective, randomized trial (LEA AUO AB 25/02). Journal of Clinical Oncology2016;34(15 suppl):4503. [DOI: 10.1200./JCO.2016.34.15_suppl.4503] GschwendJE , HeckMM , LehmannJ , RübbenH , AlbersP , WolffJM , et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. European Urology2019;75(4):604‐11. [DOI: 10.1016/j.eururo.2018.09.047; PUBMED: 30337060] NCT01215071 . A prospective randomized study for the comparison, an extended versus a limited pelvic lymphadenectomy, in the surgical therapy of bladder cancer [Prospektiv randomisierte Studie zum Vergleich einer ausgedehnten mit einer eingeschränkten pelvinen Lymphadenektomie bei der operativen Therapie des Harnblasenkarzinoms]. https://clinicaltrials.gov/ct2/show/record/NCT01215071 (first received 6 October 2010). ">Gschwend 2018</a>). For details, please refer to the ’<a href="./references#CD013336-sec-0124" title="">Characteristics of included studies</a>’ table, <a href="#CD013336-tbl-0002">Table 1</a>, and <a href="#CD013336-tbl-0003">Table 2</a>. The included trial compared extended PLND with standard PLND during RC for the treatment of bladder urothelial carcinoma. We contacted the corresponding author of this study to get additional information and received a response (<a href="./appendices#CD013336-sec-0115">Appendix 2</a>). </p> <div class="table" id="CD013336-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics of included study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study name</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial period (year to year)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting/Country</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of participants</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of follow up</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gender</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pathologic T stage</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pathologic N stage</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD013336-bbs2-0001" title="GschwendJE , HeckMM , LehmannJ , RuebbenH , AlbersP , HeidenreichA , et al. Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: survival results from a prospective, randomized trial (LEA AUO AB 25/02). Journal of Clinical Oncology2016;34(15 suppl):4503. [DOI: 10.1200./JCO.2016.34.15_suppl.4503] GschwendJE , HeckMM , LehmannJ , RübbenH , AlbersP , WolffJM , et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. European Urology2019;75(4):604‐11. [DOI: 10.1016/j.eururo.2018.09.047; PUBMED: 30337060] NCT01215071 . A prospective randomized study for the comparison, an extended versus a limited pelvic lymphadenectomy, in the surgical therapy of bladder cancer [Prospektiv randomisierte Studie zum Vergleich einer ausgedehnten mit einer eingeschränkten pelvinen Lymphadenektomie bei der operativen Therapie des Harnblasenkarzinoms]. https://clinicaltrials.gov/ct2/show/record/NCT01215071 (first received 6 October 2010). ">Gschwend 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2006 to 2010</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Multicenter/Germany</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Participants with urothelial carcinoma of the bladder who underwent radical cystectomy</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention: Extended lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>43 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median 67 (IQR:59‐74)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male: n = 151 (76.3%)</p> <p>Female: n = 47 (23.7%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T1: 31 (16%)</p> <p>T2: 88 (44%)</p> <p>T3: 63 (32%)</p> <p>T4: 16 (8.1%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nx: 2 (1.0%)</p> <p>N0: 152 (77%)</p> <p>N+: 44 (22%)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Comparator: Standard lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median 68 (IQR:61‐73)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male: n = 163 (80.3%)</p> <p>Female: n = 40 (19.7%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T1: 24 (12%)</p> <p>T2: 81 (40%)</p> <p>T3: 68 (34%)</p> <p>T4: 30 (15%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nx: 0 (0%)</p> <p>N0: 147 (72%)</p> <p>N+: 56 (28%)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>IQR: interquartile range</sup> </p> <p><sup>Nx: the lymph nodes could not be assessed</sup> </p> <p><sup>N0: no cancer found in the nearby lymph nodes</sup> </p> <p><sup>N+: cancer found in the lymph nodes</sup> </p> <p><sup>T (1, 2, 3, 4): size and extension of tumor (low to high)</sup> </p> </div> </div> <div class="table" id="CD013336-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Participants in included study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study name</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Screened/eligible (N)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Randomized (N)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Analysed (N): efficacy</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Analysed (N): safety</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Finishing trial (N (%))</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD013336-bbs2-0001" title="GschwendJE , HeckMM , LehmannJ , RuebbenH , AlbersP , HeidenreichA , et al. Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: survival results from a prospective, randomized trial (LEA AUO AB 25/02). Journal of Clinical Oncology2016;34(15 suppl):4503. [DOI: 10.1200./JCO.2016.34.15_suppl.4503] GschwendJE , HeckMM , LehmannJ , RübbenH , AlbersP , WolffJM , et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. European Urology2019;75(4):604‐11. [DOI: 10.1016/j.eururo.2018.09.047; PUBMED: 30337060] NCT01215071 . A prospective randomized study for the comparison, an extended versus a limited pelvic lymphadenectomy, in the surgical therapy of bladder cancer [Prospektiv randomisierte Studie zum Vergleich einer ausgedehnten mit einer eingeschränkten pelvinen Lymphadenektomie bei der operativen Therapie des Harnblasenkarzinoms]. https://clinicaltrials.gov/ct2/show/record/NCT01215071 (first received 6 October 2010). ">Gschwend 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention: Extended lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>458/401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173 (87.3)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Comparator: Standard lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190 (93.5)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>363 (90.5)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD013336-sec-0078"> <h5 class="title">Participants</h5> <p>A total of 458 participants were screened for enrolment. Between October 2006 and December 2010, 401 participants were randomly assigned to this trial (extended PLND, n = 198; standard PLND, n = 203). All randomized participants were included in the analysis. </p> </section> <section id="CD013336-sec-0079"> <h5 class="title">Interventions and comparators</h5> <p>The study used extended PLND as an intervention and standard PLND as a comparator. The median follow‐up duration was 43 months. </p> </section> <section id="CD013336-sec-0080"> <h5 class="title">Outcomes</h5> <p>We found reporting of all primary outcomes in the included study for this comparison. In addition, all secondary outcomes were reported for the study included, except for disease‐specific quality of life. </p> </section> <section id="CD013336-sec-0081"> <h5 class="title">Funding sources and conflicts of interest</h5> <p>A pharmaceutical company supported the study, but all authors declared no conflicts of interest. </p> </section> </section> <section id="CD013336-sec-0082"> <h4 class="title">Excluded studies</h4> <p>There were no studies excluded at the full‐text screening stage.</p> <section id="CD013336-sec-0083"> <h5 class="title"><i>Studies awaiting classification and ongoing trials</i> </h5> <p>There were no studies awaiting classification. We found one ongoing study, Southwest Oncology Group study S1011, which did not provide usable outcome data at the time that this review was written (<a href="./references#CD013336-bbs2-0002" title="LernerSP , LiH , SvatekRS , KoppieTM , AlvaAS , LaRosaFG , et al. Prerandomization factors and utilization of neoadjuvant chemotherapy in a clinical trial of extended versus standard pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer. Journal of Clinical Oncology2014;32(4 suppl):295. [DOI: 10.1200/jco.2014.32.4_suppl.295] NCT01224665 . S1011 Standard or extended pelvic lymphadenectomy in treating patients undergoing surgery for invasive bladder cancer [A phase III surgical trial to evaluate the benefit of a standard versus an extended pelvic lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer]. https://clinicaltrials.gov/ct2/show/record/NCT01224665 (first received 20 October 2010). ">NCT01224665</a>; ‘<a href="./references#CD013336-sec-0125" title="">Characteristics of ongoing studies</a>’ table). Expected date of completion is August 2022. </p> </section> </section> </section> <section id="CD013336-sec-0084"> <h3 class="title">Risk of bias in included studies</h3> <p>For details, please refer to '<a href="./references#CD013336-sec-0124" title="">Characteristics of included studies</a>' section, the 'Risk of bias' table, and the '<a href="./full#CD013336-tbl-0001">summary of findings Table for the main comparison</a>' for information on the main comparison, as well as <a href="#CD013336-fig-0002">Figure 2</a> and <a href="#CD013336-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD013336-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013336-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013336-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013336-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013336-sec-0085"> <h4 class="title">Allocation</h4> <p>Random sequence generation and allocation concealment were performed adequately; we rated the risk of bias as low. </p> </section> <section id="CD013336-sec-0086"> <h4 class="title">Blinding</h4> <section id="CD013336-sec-0087"> <h5 class="title">Performance bias</h5> <p>Participants and personnel (surgeons) were not blinded. We rated the risk of bias as high. </p> </section> <section id="CD013336-sec-0088"> <h5 class="title">Detection bias</h5> <p>Susceptible (subjective) outcomes (time to death from bladder cancer, time to recurrence, Clavien‐Dindo I‐II complications): the assessors of these outcomes were reported to be unblinded. We rated the risk of bias for these outcomes to be high. </p> <p>Not susceptible (objective) outcomes (time to death from any cause, Clavien‐Dindo III‐V complications): blinding of outcome assessors did not appear relevant to these outcomes, therefore, we rated the risk of bias for them as low. </p> </section> </section> <section id="CD013336-sec-0089"> <h4 class="title">Incomplete outcome data</h4> <p>Among 203 participants assigned to standard PLND, 13 participants did not receive standard PLND. Also, in the extended PLND group (n = 198), 25 participants did not receive extended PLND. However, all randomized participants (n = 401) were included in the analysis as intended. We judged the risk of bias as low risk for all outcomes. </p> <p>We did not rate the domain of disease‐specific quality of life because this outcome was not investigated in the trial. We reported the risk of bias as unclear in the table and figures only because this was the default value. </p> </section> <section id="CD013336-sec-0090"> <h4 class="title">Selective reporting</h4> <p>Since the study had a planned protocol, and all reported outcomes and associated analyses corresponded to how these had been planned, we assigned a judgement of low risk of reporting bias. </p> </section> <section id="CD013336-sec-0091"> <h4 class="title">Other potential sources of bias</h4> <p>No other potential sources of bias were identified.</p> </section> </section> <section id="CD013336-sec-0092"> <h3 class="title" id="CD013336-sec-0092">Effects of interventions</h3> <p>See: <a href="./full#CD013336-tbl-0001"><b>Summary of findings for the main comparison</b> Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder</a> </p> <p>Please refer to the <a href="./references#CD013336-fig-0004" title="">Analysis 1.1</a> to <a href="./references#CD013336-fig-0010" title="">Analysis 1.7</a> and <a href="./full#CD013336-tbl-0001">summary of findings Table for the main comparison</a>. We also analysed the 90‐day results for complications in the <a href="./references#CD013336-fig-0007" title="">Analysis 1.4</a> and <a href="./references#CD013336-fig-0010" title="">Analysis 1.7</a>; we did not describe this below. </p> <section id="CD013336-sec-0093"> <h4 class="title">Primary outcomes</h4> <section id="CD013336-sec-0094"> <h5 class="title">Time to death from any cause</h5> <p>Extended PLND may reduce the risk of death from any cause over time as compared to standard PLND (HR: 0.78, 95% CI: 0.57 to 1.07, participants = 401; studies = 1, <a href="./references#CD013336-fig-0004" title="">Analysis 1.1</a>, low‐certainty evidence). Based on the control event risk in this trial at 5‐year follow‐up, this corresponds to 83 fewer deaths from any cause (95% CI: 174 fewer to 24 more) per 1000 participants: 420 deaths for extended PLND compared to 503 deaths per 1000 for standard PLND. </p> <p>Based on high‐risk control groups as drawn from an observational study (<a href="./references#CD013336-bbs2-0003" title="Abd El LatifA , MiocinovicR , StephensonAJ , CampbellS , FerganyA , GongMC . Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder. Journal of Urology2012;187(Suppl 4):e707. [DOI: 10.1016/j.juro.2012.02.1768] ">Abd El‐Latif 2012</a>), also at 5‐year follow‐up, extended PLND may result in 89 fewer overall deaths (95% CI: 193 fewer to 25 more) per 1000 participants: 511 deaths for extended PLND compared to 600 deaths per 1000 participants for standard PLND. </p> <p>We rated the certainty of evidence as low due to study limitations (performance bias) and imprecision, given that the CI was consistent both with an appreciable reduction in the risk of overall deaths as well as a small or no increase in the risk of overall deaths. </p> </section> <section id="CD013336-sec-0095"> <h5 class="title">Time to death from bladder cancer</h5> <p>Extended PLND may reduce the risk of death from bladder cancer over time as compared to standard PLND (HR: 0.70, 95% CI: 0.45 to 1.07, participants = 401; studies = 1, <a href="./references#CD013336-fig-0005" title="">Analysis 1.2</a>, low‐certainty evidence). Based on the control event risk of the included trial at 5‐year follow‐up, this corresponds to 91 fewer deaths from bladder cancer (95% CI: 176 fewer to 19 more) per 1000 participants: 264 deaths for extended PLND compared to 355 deaths per 1000 participants for standard PLND. </p> <p>Based on moderate‐risk control groups as drawn from an observational study (<a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>), also at 5‐year follow‐up, extended PLND may result in 114 fewer bladder cancer deaths (95% CI: 229 fewer to 24 more) per 1000 participants: 377 deaths for extended PLND compared to 491 deaths per 1000 participants for standard PLND. </p> <p>We rated the certainty of evidence as low due to study limitations (performance and detection bias) and imprecision, given that the CI was consistent both with an appreciable reduction in the risk of bladder cancer deaths as well as a small or no increase in the risk of bladder cancer deaths. </p> </section> <section id="CD013336-sec-0096"> <h5 class="title">Clavien‐Dindo grade ≥ 3 complications</h5> <p>We are uncertain whether extended PLND results in more Clavien‐Dindo grade ≥ 3 complications as compared to standard PLND (RR: 1.13, 95% CI: 0.84 to 1.52, participants = 401; studies = 1, <a href="./references#CD013336-fig-0006" title="">Analysis 1.3</a>, very low‐certainty evidence). Based on the control event risk in the trial and 30‐day follow‐up, this corresponds to 37 more complications (95% CI: 46 fewer to 149 more) per 1000 participants: 323 complications for extended PLND compared to 286 complications per 1000 participants for standard PLND. </p> <p>Based on the high‐risk control groups as coming from an observational study (<a href="./references#CD013336-bbs2-0008" title="BrossnerC , PychaA , TothA , MianC , KuberW . Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU International2004;93(1):64‐6. [PUBMED: 14678370] ">Brossner 2004</a>) also at 30‐day follow‐up, extended PLND may result in 73 more complications (95% CI: 90 fewer to 294 more) per 1000 participants: 638 complications for extended PLND compared to 565 complications per 1000 participants for standard PLND. </p> <p>We downgraded the certainty of evidence by one level due to study limitations, namely performance bias, and by two levels due to imprecision, given that the CI was consistent both with a small reduction in complications, as well as an appreciable increase in the Clavien‐Dindo grade ≥ 3 complications. </p> </section> </section> <section id="CD013336-sec-0097"> <h4 class="title">Secondary outcomes</h4> <section id="CD013336-sec-0098"> <h5 class="title">Time to recurrence</h5> <p>We are uncertain whether extended PLND reduces the risk of recurrence over time as compared to standard PLND (HR: 0.84, 95% CI: 0.58 to 1.22, participants = 401; studies = 1, <a href="./references#CD013336-fig-0008" title="">Analysis 1.5</a>, very low‐certainty evidence). Based on the control event risk in the trial included in this analysis and 5‐year follow‐up, this corresponds to 52 fewer recurrences (95% CI: 146 fewer to 64 more) per 1000 participants: 356 recurrences for extended PLND compared to 408 recurrences per 1000 participants for standard PLND. </p> <p>Based on the moderate‐ and high‐risk control groups, as drawn from separate observational studies (<a href="./references#CD013336-bbs2-0004" title="Abol‐EneinH , TilkiD , MosbahA , El‐BazM , ShokeirA , NabeehA , et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease‐free survival? A prospective single‐center study. European Urology2011;60(3):572‐7. [PUBMED: 21684070] ">Abol‐Enein 2011</a>; <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>) at 5‐year follow‐up, extended PLND may result in 55 fewer recurrences (95% CI: 158 fewer to 68 more) per 1000 participants: 398 recurrences for extended PLND compared to 453 recurrences per 1000 participants for standard PLND or 62 fewer recurrences (95% CI: 184 fewer to 73 more) per 1000 participants: 512 recurrences for extended PLND compared to 574 recurrences per 1000 participants for standard PLND, respectively. We rated the certainty of evidence to be very low due to study limitations (due to performance and detection bias) as well as imprecision, given that the CI was consistent both with an appreciable reduction in the risk of recurrence, as well as a small increase in the risk of recurrences. </p> </section> <section id="CD013336-sec-0099"> <h5 class="title">Clavien‐Dindo grade ≤ 2 complications</h5> <p>The evidence is uncertain whether extended PLND results in similar Clavien‐Dindo grade ≤ 2 complications compared to standard PLND.(RR: 0.94, 95% CI: 0.74 to 1.19, participants = 401; studies = 1, <a href="./references#CD013336-fig-0009" title="">Analysis 1.6</a>, very low‐certainty evidence). Based on the control event risk in the trial included in this analysis and a 30‐day follow‐up, this corresponds to 25 fewer complications (95% CI: 108 fewer to 79 more) per 1000 participants: 389 complications for extended PLND compared to 414 complications per 1000 participants for standard PLND. We downgraded the certainty of evidence by one level due to study limitations, namely performance bias and detection bias, and by two levels due to imprecision, given that the CI was consistent both with an appreciable reduction in complications, as well as a small increase in the Clavien‐Dindo grade ≤ 2 complications. </p> </section> <section id="CD013336-sec-0100"> <h5 class="title">Disease‐specific quality of life</h5> <p>We found no studies that reported this outcome.</p> </section> </section> <section id="CD013336-sec-0101"> <h4 class="title">Subgroup analysis</h4> <p>We were unable to obtain sufficient information to perform the planned subgroup analyses.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013336-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013336-sec-0102"></div> <section id="CD013336-sec-0103"> <h3 class="title" id="CD013336-sec-0103">Summary of main results</h3> <p>We included only one RCT with 401 participants. The findings of this systematic review indicate that extended PLND may reduce overall mortality and bladder cancer mortality over time but both results include the possibility of no effect. The evidence is uncertain about the effect of extended PLND on time to recurrence. </p> <p>With regard to complications, we are uncertain whether extended PLND increases Clavien‐Dindo grade ≥ 3 complications and results in similar Clavien‐Dindo grade ≤ 2 complications for up to 30 days. </p> <p>We were unable to find evidence for the effect of extended PLND on disease‐specific quality of life and were unable to conduct any of our preplanned secondary analyses based on lymph node dissection templates, tumor stage or receipt of neoadjuvant chemotherapy. </p> </section> <section id="CD013336-sec-0104"> <h3 class="title" id="CD013336-sec-0104">Overall completeness and applicability of evidence</h3> <p>Findings of this review were based on only one RCT that was performed by experienced high‐volume surgeons at tertiary medical centers which may limit the generalizability of its findings. Quality control of the treatment arms could have been improved by measures such as intraoperative photographs taken to ensure the completeness of extended PLND and to document that dissection in the standard PLND arm did not extend beyond the intended boundaries. Moreover, the study did not investigate the effect of extended PLND in a neoadjuvant or adjuvant setting which are recommended by current guidelines (<a href="./references#CD013336-bbs2-0011" title="ChangSS , BochnerBH , ChouR , DreicerR , KamatAM , LernerSP , et al. Treatment of non‐metastatic muscle‐Invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. Journal of Urology2017;198(3):552‐9. [PUBMED: 28456635] ">Chang 2017</a>; <a href="./references#CD013336-bbs2-0014" title="European Association of Urology. Muscle‐invasive and metastatic bladder cancer. uroweb.org/guideline/bladder‐cancer‐muscle‐invasive‐and‐metastatic/ (accessed 7 January 2019). ">EAU Guideline 2018</a>; <a href="./references#CD013336-bbs2-0034" title="Bladder Cancer, NCCN Clinical Practice Guidelines in Oncology. www.nccn.org/professionals/physician_gls/default.aspx#site (accessed 7 January 2019), issue 1. ">NCCN Guideline 2019</a>) and may represent effect modifiers. </p> </section> <section id="CD013336-sec-0105"> <h3 class="title" id="CD013336-sec-0105">Quality of the evidence</h3> <p>Overall, we judged the potential risk of bias of the included trial as unclear. While the study used appropriate methods of randomization and allocation concealment, thereby raising no concerns about selection bias, it used an open‐label design (no blinding of participants and personnel) raising concerns about performance bias. Also, outcome assessors were not blinded raising concerns about detection bias. The latter does not apply to outcomes that could be objectively measured such as time to death from any cause and Clavien‐Dindo III‐V complications for which we judged the risk of detection bias as low. Since all randomized participants were included in the analyses for all investigated outcomes, we judged the risk of attrition bias as low. </p> <p>We judged the certainty of the evidence body as low or very low for most outcomes due to these study limitations as well as wide confidence intervals and resulting clinically important imprecision of the results. For the Clavien‐Dindo complications and time to recurrence outcomes, we judged the certainty of the evidence body as very low, due to the aforementioned reasons. In addition, very wide confidence intervals led to downgrading (two levels) for imprecision. </p> </section> <section id="CD013336-sec-0106"> <h3 class="title" id="CD013336-sec-0106">Potential biases in the review process</h3> <p> <ul id="CD013336-list-0021"> <li> <p>It is possible (although unlikely) that additional studies may have been conducted but not yet published, or that we failed to identify additional studies that do exist despite our comprehensive search. </p> </li> <li> <p>The study included some clinical stage T1 disease participants. Given that the aggressiveness of cancer is somewhat different from that of muscle‐invasive disease (clinical stage ≥ T2 disease), this could be a source of bias, possibly resulting in an underestimate of the effect size. </p> </li> </ul> </p> </section> <section id="CD013336-sec-0107"> <h3 class="title" id="CD013336-sec-0107">Agreements and disagreements with other studies or reviews</h3> <p>We identified four systematic reviews with nonrandomized controlled trials on this topic (<a href="./references#CD013336-bbs2-0006" title="BiL , HuangH , FanX , LiK , XuK , JiangC , et al. Extended vs non‐extended pelvic lymph node dissection and their influence on recurrence‐free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta‐analysis of comparative studies. BJU International2014;113(5b):E39‐48. [PUBMED: 24053715] ">Bi 2014</a>; <a href="./references#CD013336-bbs2-0009" title="BruinsHM , VeskimaeE , HernandezV , ImamuraM , NeubergerMM , DahmP , et al. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. European Urology2014;66(6):1065‐77. [PUBMED: 25074764] ">Bruins 2014</a>; <a href="./references#CD013336-bbs2-0036" title="PalmerD , ClubbA , DuboyAJ , NeubergerMM , GilbertSM , DahmP . The therapeutic benefit of an extended lymph node dissection in radical cystectomy: a systematic review and meta‐analysis of observational studies applying the novel Cochrane risk of bias tool. Journal of Urology2011;185(4):e742. [DOI: 10.1016/j.juro.2011.02.1883] ">Palmer 2011</a>; <a href="./references#CD013336-bbs2-0048" title="TilkiD , BrausiM , ColomboR , EvansCP , FradetY , FritscheHM , et al. Lymphadenectomy for bladder cancer at the time of radical cystectomy. European Urology2013;64(2):266‐76. [PUBMED: 23648149] ">Tilki 2013</a>). </p> <p><a href="./references#CD013336-bbs2-0006" title="BiL , HuangH , FanX , LiK , XuK , JiangC , et al. Extended vs non‐extended pelvic lymph node dissection and their influence on recurrence‐free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta‐analysis of comparative studies. BJU International2014;113(5b):E39‐48. [PUBMED: 24053715] ">Bi 2014</a> performed a systematic review that included six studies comparing extended PLND and nonextended PLND. The definition of LND template in their review was similar to that used in our review. In line with our results, the pooled data indicated that extended PLND provided a better recurrence‐free survival as compared to nonextended PLND. Subgroup analysis showed that participants with ≥ pathologic T3 disease and regardless of lymph node involvement, also had a recurrence‐free survival benefit from extended PLND. The level of evidence (LOE) of the included studies was rated according to the criteria developed by the Centre for Evidence‐Based Medicine in Oxford, UK, (<a href="./references#CD013336-bbs2-0035" title='HowickJ , ChalmersI , GlasziouP , GreenhalghT , HeneghanC , LiberatiA , et al. Oxford Center for Evidence‐Based Medicine. "The Oxford 2011 Levels of Evidence".. www.cebm.net/index.aspx?o=5653 (accessed 3 January 2019). '>OCEBM Levels of Evidence Working Group</a>) but the risk of bias was not assessed. </p> <p><a href="./references#CD013336-bbs2-0009" title="BruinsHM , VeskimaeE , HernandezV , ImamuraM , NeubergerMM , DahmP , et al. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. European Urology2014;66(6):1065‐77. [PUBMED: 25074764] ">Bruins 2014</a> performed a systematic review that included 23 studies to evaluate the impact of the extent of LND on oncologic outcomes. They could not perform a meta‐analysis due to study heterogeneity; instead, they assessed the risk of bias using the risk of bias tool developed by Cochrane (<a href="./references#CD013336-bbs2-0039" title="ReevesBC , DeeksJJ , HigginsJPT , WellsGA . Chapter 13: Including non‐randomized studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Reeves 2011</a>). They concluded that despite the poor quality of the data, extended PLND might improve oncologic outcomes as compared to lesser degrees of dissection, although extending the dissection up to inferior mesenteric artery was unlikely to yield any further benefits. Moreover, extended PLND seemed to not increase perioperative morbidity. These results are somewhat different from our results. </p> <p><a href="./references#CD013336-bbs2-0036" title="PalmerD , ClubbA , DuboyAJ , NeubergerMM , GilbertSM , DahmP . The therapeutic benefit of an extended lymph node dissection in radical cystectomy: a systematic review and meta‐analysis of observational studies applying the novel Cochrane risk of bias tool. Journal of Urology2011;185(4):e742. [DOI: 10.1016/j.juro.2011.02.1883] ">Palmer 2011</a> performed a systematic review, including three studies that compared extended and limited PLND. The pooled relative risk for recurrence‐free survival was 1.23 (95% CI 1.07 to 1.42; P = 0.004) in favour of extended PLND. However, they did not provide information on the overall or disease‐specific survival or detailed findings regarding the complications. They rated the certainty of evidence using GRADE and assessed the risk of bias using the risk of bias tool developed by Cochrane (<a href="./references#CD013336-bbs2-0039" title="ReevesBC , DeeksJJ , HigginsJPT , WellsGA . Chapter 13: Including non‐randomized studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Reeves 2011</a>). </p> <p><a href="./references#CD013336-bbs2-0048" title="TilkiD , BrausiM , ColomboR , EvansCP , FradetY , FritscheHM , et al. Lymphadenectomy for bladder cancer at the time of radical cystectomy. European Urology2013;64(2):266‐76. [PUBMED: 23648149] ">Tilki 2013</a> summarized the existing data on the value of lymphadenectomy for staging and disease‐free survival. They concluded that extended PLND may influence disease‐free survival. However, they included several studies that evaluated the use of lymph node retrieval count as a surrogate for the extent of LND. It seems inaccurate to use the LN count to represent the extent of the LND template, instead of using an anatomic landmark (<a href="./references#CD013336-bbs2-0013" title="DorinRP , DaneshmandS , EisenbergMS , ChandrasomaS , CaiJ , MirandaG , et al. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. European Urology2011;60(5):946‐52. [PUBMED: 21802833] ">Dorin 2011</a>; <a href="./references#CD013336-bbs2-0033" title="MeijerRP , NunninkCJ , WassenaarAE , BexA , Van derPoelHG , VanRhijnBW , et al. Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes. Journal of Urology2012;187(2):446‐50. [PUBMED: 22177147] ">Meijer 2012</a>). </p> <p>This systematic review is the first to focus on the RCT results for both oncologic outcomes and intervention‐related complications and providing absolute effect size estimates. We believe that our systematic review provides the most reliable summary of evidence on this topic to date. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013336-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013336-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013336-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013336-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Extended versus standard lymph node dissection, Outcome 1 Time to death from any cause." data-id="CD013336-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Extended versus standard lymph node dissection, Outcome 1 Time to death from any cause. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Extended versus standard lymph node dissection, Outcome 2 Time to death from bladder cancer." data-id="CD013336-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Extended versus standard lymph node dissection, Outcome 2 Time to death from bladder cancer. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Extended versus standard lymph node dissection, Outcome 3 Clavien‐Dindo III‐V complications (up to 30 days)." data-id="CD013336-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Extended versus standard lymph node dissection, Outcome 3 Clavien‐Dindo III‐V complications (up to 30 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Extended versus standard lymph node dissection, Outcome 4 Clavien‐Dindo III‐V complications (up to 90 days)." data-id="CD013336-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Extended versus standard lymph node dissection, Outcome 4 Clavien‐Dindo III‐V complications (up to 90 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Extended versus standard lymph node dissection, Outcome 5 Time to recurrence." data-id="CD013336-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Extended versus standard lymph node dissection, Outcome 5 Time to recurrence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Extended versus standard lymph node dissection, Outcome 6 Clavien‐Dindo I‐II complications (up to 30 days)." data-id="CD013336-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Extended versus standard lymph node dissection, Outcome 6 Clavien‐Dindo I‐II complications (up to 30 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013336-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/urn:x-wiley:14651858:media:CD013336:CD013336-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_t/tCD013336-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Extended versus standard lymph node dissection, Outcome 7 Clavien‐Dindo I‐II complications (up to 90 days)." data-id="CD013336-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Extended versus standard lymph node dissection, Outcome 7 Clavien‐Dindo I‐II complications (up to 90 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013336/media/CDSR/CD013336/image_n/nCD013336-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013336-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Participant or population:</b> Partcipants with bladder cancer undergoing radical cystectomy (male n = 314, female n = 87; age (interquartile range) 59 to 74)<br/> <b>Country:</b> Germany </p> <p><b>Setting:</b> Muticenter/Inpatient <br/> <b>Intervention:</b> Extended lymph node (LN) dissection<br/> <b>Comparison:</b> Standard lymph node (LN) dissection </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard LN dissection</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with Extended LN dissection</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Time to death from any cause</b> </p> <p>(absolute effect size estimates based on death rate at 5 years)<br/> follow‐up: median 43 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>HR 0.78<br/> (0.57 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>503 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83 fewer per 1,000<br/> (174 fewer to 24 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>600 per 1,000 <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89 fewer per 1,000<br/> (193 fewer to 25 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Time to death from bladder cancer</b> </p> <p>(absolute effect size estimates based on death rate at 5 years)<br/> follow‐up: median 43 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>HR 0.70<br/> (0.45 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>355 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 fewer per 1,000<br/> (176 fewer to 19 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>491 per 1,000 <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>114 fewer per 1,000<br/> (229 fewer to 24 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Clavien‐Dindo grade ≥ 3 complications</b><br/> assessed with: Clavien‐Dindo classification (Grade 1 to 5; high grade represents severe complication)<br/> follow‐up: 30 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.13<br/> (0.84 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 more per 1,000<br/> (46 fewer to 149 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>565 per 1,000 <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 more per 1,000<br/> (90 fewer to 294 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Time to recurrence</b> </p> <p>(absolute effect size estimates based on recurrence rate at 5 years)<br/> follow‐up: median 43 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="6" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="6" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>HR 0.84<br/> (0.58 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 fewer per 1,000<br/> (146 fewer to 64 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>453 per 1,000 <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 fewer per 1,000<br/> (158 fewer to 68 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>High</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>574 per 1,000 <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62 fewer per 1,000<br/> (184 fewer to 73 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clavien‐Dindo grade ≤ 2 complications</b><sup>8</sup> <br/> assessed with: Clavien‐Dindo classification (Grade 1 to 5; high grade represents severe complication)<br/> follow‐up: 30 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>401<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94<br/> (0.74 to 1.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>414 per 1,000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 fewer per 1,000<br/> (108 fewer to 79 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Disease‐specific quality of life</b><sup>9</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; <b>LN:</b> Lymph node; <b>RR:</b> Risk ratio; <b>RCT</b>: Randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level for study limitations: high risk of performance and detection bias </p> <p><sup>2</sup> Downgraded by one level for imprecision: confidence interval crossed the line of no difference and the assumed threshold of a clinically important difference (included benefit and no benefit) </p> <p><sup>3</sup> Baseline risk for death from any cause in the standard LN dissection group was assumed to be 60% (high risk) at 5 years as reported in <a href="./references#CD013336-bbs2-0003" title="Abd El LatifA , MiocinovicR , StephensonAJ , CampbellS , FerganyA , GongMC . Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder. Journal of Urology2012;187(Suppl 4):e707. [DOI: 10.1016/j.juro.2012.02.1768] ">Abd El‐Latif 2012</a>; observational study. </p> <p><sup>4</sup> Baseline risk for death from bladder cancer in the standard LN dissection group was assumed to be 49.1% (high risk) at 5 years as reported in <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>; observational study. </p> <p><sup>5</sup> Downgraded by two levels for imprecision: confidence interval crossed the line of no difference and the assumed threshold of a clinically important difference; wide confidence interval (included both benefit and harm) </p> <p><sup>6</sup> Baseline risk for Clavien‐Dindo grade ≥ 3 complications in the standard LN dissection group was assumed to be 56.5% (high risk) at 30 days as reported in <a href="./references#CD013336-bbs2-0008" title="BrossnerC , PychaA , TothA , MianC , KuberW . Does extended lymphadenectomy increase the morbidity of radical cystectomy?. BJU International2004;93(1):64‐6. [PUBMED: 14678370] ">Brossner 2004</a>; observational study. </p> <p><sup>7</sup> Baseline risk for recurrence in the standard LN dissection group was assumed to be 45.3% (moderate risk) and 57.3% (high risk) at 5 years as reported in <a href="./references#CD013336-bbs2-0004" title="Abol‐EneinH , TilkiD , MosbahA , El‐BazM , ShokeirA , NabeehA , et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease‐free survival? A prospective single‐center study. European Urology2011;60(3):572‐7. [PUBMED: 21684070] ">Abol‐Enein 2011</a> and in <a href="./references#CD013336-bbs2-0043" title="SimoneG , PapaliaR , FerrieroM , GuaglianoneS , CastelliE , ColluraD , et al. Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. International Journal of Urology2013;20(4):390‐7. [PUBMED: 22970939] ">Simone 2013</a>, respectively; both observational studies. </p> <p><sup>8</sup> We could not ascertain this outcome in observational studies </p> <p><sup>9</sup> Disease‐specific quality of life: no available data </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Impact of extended versus standard lymph node dissection on overall survival among patients with urothelial cancer of the bladder</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013336-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics of included study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study name</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial period (year to year)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting/Country</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Description of participants</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of follow up</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gender</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pathologic T stage</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pathologic N stage</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD013336-bbs2-0001" title="GschwendJE , HeckMM , LehmannJ , RuebbenH , AlbersP , HeidenreichA , et al. Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: survival results from a prospective, randomized trial (LEA AUO AB 25/02). Journal of Clinical Oncology2016;34(15 suppl):4503. [DOI: 10.1200./JCO.2016.34.15_suppl.4503] GschwendJE , HeckMM , LehmannJ , RübbenH , AlbersP , WolffJM , et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. European Urology2019;75(4):604‐11. [DOI: 10.1016/j.eururo.2018.09.047; PUBMED: 30337060] NCT01215071 . A prospective randomized study for the comparison, an extended versus a limited pelvic lymphadenectomy, in the surgical therapy of bladder cancer [Prospektiv randomisierte Studie zum Vergleich einer ausgedehnten mit einer eingeschränkten pelvinen Lymphadenektomie bei der operativen Therapie des Harnblasenkarzinoms]. https://clinicaltrials.gov/ct2/show/record/NCT01215071 (first received 6 October 2010). ">Gschwend 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>2006 to 2010</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Multicenter/Germany</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Participants with urothelial carcinoma of the bladder who underwent radical cystectomy</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention: Extended lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>43 months</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median 67 (IQR:59‐74)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male: n = 151 (76.3%)</p> <p>Female: n = 47 (23.7%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T1: 31 (16%)</p> <p>T2: 88 (44%)</p> <p>T3: 63 (32%)</p> <p>T4: 16 (8.1%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nx: 2 (1.0%)</p> <p>N0: 152 (77%)</p> <p>N+: 44 (22%)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Comparator: Standard lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median 68 (IQR:61‐73)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male: n = 163 (80.3%)</p> <p>Female: n = 40 (19.7%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T1: 24 (12%)</p> <p>T2: 81 (40%)</p> <p>T3: 68 (34%)</p> <p>T4: 30 (15%)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nx: 0 (0%)</p> <p>N0: 147 (72%)</p> <p>N+: 56 (28%)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>IQR: interquartile range</sup> </p> <p><sup>Nx: the lymph nodes could not be assessed</sup> </p> <p><sup>N0: no cancer found in the nearby lymph nodes</sup> </p> <p><sup>N+: cancer found in the lymph nodes</sup> </p> <p><sup>T (1, 2, 3, 4): size and extension of tumor (low to high)</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics of included study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013336-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Participants in included study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study name</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Screened/eligible (N)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Randomized (N)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Analysed (N): efficacy</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Analysed (N): safety</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Finishing trial (N (%))</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD013336-bbs2-0001" title="GschwendJE , HeckMM , LehmannJ , RuebbenH , AlbersP , HeidenreichA , et al. Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: survival results from a prospective, randomized trial (LEA AUO AB 25/02). Journal of Clinical Oncology2016;34(15 suppl):4503. [DOI: 10.1200./JCO.2016.34.15_suppl.4503] GschwendJE , HeckMM , LehmannJ , RübbenH , AlbersP , WolffJM , et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. European Urology2019;75(4):604‐11. [DOI: 10.1016/j.eururo.2018.09.047; PUBMED: 30337060] NCT01215071 . A prospective randomized study for the comparison, an extended versus a limited pelvic lymphadenectomy, in the surgical therapy of bladder cancer [Prospektiv randomisierte Studie zum Vergleich einer ausgedehnten mit einer eingeschränkten pelvinen Lymphadenektomie bei der operativen Therapie des Harnblasenkarzinoms]. https://clinicaltrials.gov/ct2/show/record/NCT01215071 (first received 6 October 2010). ">Gschwend 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention: Extended lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>458/401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>173 (87.3)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Comparator: Standard lymph node dissection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>203</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190 (93.5)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Total</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>401</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>363 (90.5)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Participants in included study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013336/full#CD013336-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013336-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Extended versus standard lymph node dissection</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Time to death from any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Time to death from bladder cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clavien‐Dindo III‐V complications (up to 30 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clavien‐Dindo III‐V complications (up to 90 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Clavien‐Dindo I‐II complications (up to 30 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Clavien‐Dindo I‐II complications (up to 90 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Extended versus standard lymph node dissection</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013336/references#CD013336-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013336&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD013336-note-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD013336-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013336-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013336-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD013336-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013336-note-0005">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013336\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013336"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013336\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013336\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013336"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013336\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013336"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013336\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013336\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013336"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013336&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013336';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013336/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013336/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013336%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725187141"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013336/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725187145"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013336/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e751a09c51be5',t:'MTc0MDcyNTE4Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 